Literature DB >> 16613595

Thoracic organ transplantation in the United States, 1995-2004.

J B Orens1, T H Shearon, R S Freudenberger, R S Freudenburger, J V Conte, S M Bhorade, A Ardehali.   

Abstract

This article reviews trends in thoracic organ transplantation based on OPTN/SRTR data from 1995 to 2004. The number of active waiting list patients for heart transplants continues to decline, primarily because there are fewer patients with coronary artery disease listed for transplantation. Waiting times for heart transplantation have decreased, and waiting list deaths also have declined, from 259 per 1000 patient-years at risk in 1995 to 156 in 2004. Fewer heart transplants were performed in 2004 than in 1995, but adjusted patient survival increased to 88% at 1 year and 73% at 5 years. Emphysema, idiopathic pulmonary fibrosis and cystic fibrosis were the most common indications among lung transplant recipients in 2004. Waiting time for lung transplantation decreased between 1999 and 2004. Waiting list mortality decreased to 134 per 1000 patient-years at risk in 2004. One-year survival following transplantation has improved significantly in the past decade. The number of combined heart-lung transplants performed in the United States remains low, with only 39 performed in 2004. Overall unadjusted survival, at 58% at 1 year and 40% at 5 years, is lower among heart-lung recipients than among either heart or lung recipients alone.

Entities:  

Mesh:

Year:  2006        PMID: 16613595     DOI: 10.1111/j.1600-6143.2006.01274.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  6 in total

Review 1.  Peripheral blood biomarkers in idiopathic pulmonary fibrosis.

Authors:  Rekha Vij; Imre Noth
Journal:  Transl Res       Date:  2012-02-02       Impact factor: 7.012

Review 2.  Heart-lung transplantation: pediatric indications and outcomes.

Authors:  Jonathan E Spahr; Shawn C West
Journal:  J Thorac Dis       Date:  2014-08       Impact factor: 2.895

3.  Lung transplantation disparities based on diagnosis for patients bridging to transplant on extracorporeal membrane oxygenation.

Authors:  David Furfaro; Erika B Rosenzweig; Lori Shah; Hilary Robbins; Michaela Anderson; Hanyoung Kim; Darryl Abrams; Cara L Agerstrand; Daniel Brodie; Danielle Feldhaus; Joseph Costa; Philippe Lemaitre; Bryan P Stanifer; Frank D'Ovidio; Joshua R Sonett; Selim Arcasoy; Luke Benvenuto
Journal:  J Heart Lung Transplant       Date:  2021-08-25       Impact factor: 13.569

4.  Impact of the lung allocation score on lung transplantation for pulmonary arterial hypertension.

Authors:  Hubert Chen; Stephen C Shiboski; Jeffrey A Golden; Michael K Gould; Steven R Hays; Charles W Hoopes; Teresa De Marco
Journal:  Am J Respir Crit Care Med       Date:  2009-06-11       Impact factor: 21.405

Review 5.  Role of melatonin in respiratory diseases (Review).

Authors:  Lijie Li; Xiaochao Gang; Jiajia Wang; Xiaoyan Gong
Journal:  Exp Ther Med       Date:  2022-02-09       Impact factor: 2.447

Review 6.  Protein Arginine Methyltransferases (PRMTs): promising targets for the treatment of pulmonary disorders.

Authors:  Dariusz Zakrzewicz; Anna Zakrzewicz; Klaus T Preissner; Philipp Markart; Malgorzata Wygrecka
Journal:  Int J Mol Sci       Date:  2012-09-27       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.